Cardiovascular Disease (CVD) Completed Phase 3 Trials for Dapagliflozin (DB06292)

Also known as: Cardio Vascular Disease / Cardiovascular Diseases / Cardio-vascular Disease / Cardiovascular Disease / Cardio-vascular Diseases / Diseases, Cardiovascular / Cardiovascular disease, unspecified / Heart diseases / Cardiovascular disorder / Cardiovascular disorder NOS / Disorder cardiovascular (NOS) / Cardiovascular disorder (NOS)

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01031680Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionTreatment
NCT01042977Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseTreatment